Peter Wehrwein has been the lead editor of Managed Healthcare Executive since February 2020.
Will Congress Pass PBM Legislation This Year? It Is 'Highly Likely,' Says Patrick Cooney | PBMI 2024
September 6th 2024Patrick Cooney, president of The Federal Group, a Washington, D.C., lobbying firm says prospects for legislation passing this year, albeit during the post-election lameduck session, are good partly because the PBM legislation would produce Medicare savings that could be put toward other uses.
Read More
Cell and Gene Therapy: Becoming More Ordinary. Still Extraordinarily Expensive
September 3rd 2024Cell and gene therapies are becoming almost an everyday clinical reality. But the price tags? They still have shock value. Payers and providers are working out single-case agreements ahead of when the therapies are given.
Read More
With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift | AIDS 2024
July 25th 2024Phase 3 trials reported at the International AIDS Society meeting this week show no infections among those randomly assigned to twice-year injections of lenacapavir and no reason to be worried about safety,.
Read More